← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 30, 2024Last known activity
Sep 12, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 6 trials)
Phase 4 (4 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Recent trials (17)
- NCT07166640Lead sponsorN/ASep 12, 2025
- NCT07166640Sponsor investigatorN/ASep 12, 2025
- NCT07166640OfficialN/ASep 12, 2025
- NCT07162805Sponsor investigatorN/ASep 8, 2025
- NCT07162805OfficialN/ASep 8, 2025
- NCT07162805Lead sponsorN/ASep 8, 2025
- NCT07123870Sponsor investigatorPhase 4Jul 23, 2025
- NCT07123870Lead sponsorPhase 4Jul 23, 2025
- NCT07123870OfficialPhase 4Jul 23, 2025
- NCT06832683OfficialN/AMar 31, 2025
- NCT06832683Lead sponsorN/AMar 31, 2025
- NCT06832683Sponsor investigatorN/AMar 31, 2025
- NCT06457958OfficialPhase 4Nov 1, 2024
- NCT06457958Lead sponsorPhase 4Nov 1, 2024
- NCT06498869Sponsor investigatorN/AJul 30, 2024
Details
- Last known activity
- Sep 12, 2025